Does cellular heterogeneity influence neuroblastoma cell line proliferation and invasiveness with granulocyte colony-stimulating factor?
Botting
Rachel A
RA
McLachlan
Craig S
CS
D045744:Cell Line, Tumor / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D005434:Flow Cytometry / Q000706:statistics & numerical data; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D009361:Neoplasm Invasiveness / Q000473:pathology; D009447:Neuroblastoma / Q000188:drug therapy / Q000473:pathology*; D009503:Neutropenia / Q000188:drug therapy*; D016188:Receptors, Granulocyte Colony-Stimulating Factor / Q000187:drug effects; D055502:Secondary Prevention
D016188:Receptors, Granulocyte Colony-Stimulating Factor; D016179:Granulocyte Colony-Stimulating Factor